TELA Bio Inc
Research TELA Bio Inc (TELA) on Bullrun: market cap USD 36.76M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerTELA
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 36.76M
- Financial periodQ3 2026
- RevenueUSD 18.96M
- Net income-USD 9.30M
- Free cash flow-USD 8.70M
- Gross margin64.9%
Valuation Snapshot
latest market cap is USD 36.76M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 80.28M | -USD 38.80M | -USD 28.67M | 67.7% | -0.83 | USD 50.85M | USD 55.65M | USD 6.31M |
| FY2024 | USD 69.30M | -USD 37.80M | -USD 42.58M | 67.1% | -1.33 | USD 52.67M | USD 41.12M | USD 28.46M |
| FY2023 | USD 58.45M | -USD 46.70M | -USD 41.47M | 68.6% | -2.04 | USD 46.73M | USD 40.52M | USD 18.88M |
| FY2022 | USD 41.42M | -USD 44.30M | -USD 41.62M | 65.3% | -2.72 | USD 42.02M | USD 39.92M | USD 14.31M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-11-06 | USD 36.76M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 52.56M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 118.98M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 162.12M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 220.33M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 185.98M | n/a | n/a | n/a |
About TELA Bio Inc
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction;
ETFs that hold TELA Bio Inc
US-listed ETFs
TELA Bio Inc is held by 2 US-listed ETFs, going by the latest portfolios they filed with the SEC, most traded first:
| ETF | Weight | Fee |
|---|---|---|
| Vanguard Morningstar Total Stock Market ETF (VTI) | <0.01% | 0.03% |
| Vanguard Extended Market Index Fund ETF Shares (VXF) | <0.01% | 0.05% |
Portfolios as filed with the SEC on Form N-PORT, dated June 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is TELA Bio Inc's market cap?
TELA Bio Inc's market capitalization is USD 36.76M.
What does TELA Bio Inc do?
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy.